247 related articles for article (PubMed ID: 38449871)
21. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment.
Zhu S; Wang Y; Tang J; Cao M
Front Immunol; 2022; 13():1074477. PubMed ID: 36532071
[TBL] [Abstract][Full Text] [Related]
22. Nanotechnology-enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial-based radio-immunotherapy.
Viswanath D; Park J; Misra R; Pizzuti VJ; Shin SH; Doh J; Won YY
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1924. PubMed ID: 37632203
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy, PARP Inhibition, and Immune-Checkpoint Blockade: A Triad to Overcome the Double-Edged Effects of Each Single Player.
Rosado MM; Pioli C
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831435
[TBL] [Abstract][Full Text] [Related]
24. Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1.
Tan H; Liu J; Huang J; Li Y; Xie Q; Dong Y; Mi Z; Ma X; Rong P
J Transl Med; 2023 Jul; 21(1):462. PubMed ID: 37438720
[TBL] [Abstract][Full Text] [Related]
25. Radiation-induced immune response in novel radiotherapy approaches FLASH and spatially fractionated radiotherapies.
Bertho A; Iturri L; Prezado Y
Int Rev Cell Mol Biol; 2023; 376():37-68. PubMed ID: 36997269
[TBL] [Abstract][Full Text] [Related]
26. Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments.
Procureur A; Simonaggio A; Bibault JE; Oudard S; Vano YA
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33567530
[TBL] [Abstract][Full Text] [Related]
27. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
[TBL] [Abstract][Full Text] [Related]
28. Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.
Derer A; Deloch L; Rubner Y; Fietkau R; Frey B; Gaipl US
Front Immunol; 2015; 6():505. PubMed ID: 26500646
[TBL] [Abstract][Full Text] [Related]
29. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
[TBL] [Abstract][Full Text] [Related]
30. Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice.
Zhou H; Tu C; Yang P; Li J; Kepp O; Li H; Zhang L; Zhang L; Zhao Y; Zhang T; Sheng C; Wang J
Oncoimmunology; 2022; 11(1):2057892. PubMed ID: 35355680
[TBL] [Abstract][Full Text] [Related]
31. Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes.
Yasmin-Karim S; Ziberi B; Wirtz J; Bih N; Moreau M; Guthier R; Ainsworth V; Hesser J; Makrigiorgos GM; Chuong MD; Wei X; Nguyen PL; Ngwa W
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):475-486. PubMed ID: 34530092
[TBL] [Abstract][Full Text] [Related]
32. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
33. Abscopal Effect of Radiotherapy Enhanced with Immune Checkpoint Inhibitors of Triple Negative Breast Cancer in 4T1 Mammary Carcinoma Model.
Song HN; Jin H; Kim JH; Ha IB; Kang KM; Choi HS; Jeong HJ; Kim MY; Kim HJ; Jeong BK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638817
[TBL] [Abstract][Full Text] [Related]
34. Narrative review of emerging roles for AKT-mTOR signaling in cancer radioimmunotherapy.
Shen C; He Y; Chen Q; Feng H; Williams TM; Lu Y; He Z
Ann Transl Med; 2021 Oct; 9(20):1596. PubMed ID: 34790802
[TBL] [Abstract][Full Text] [Related]
35. Biomineralized MnO
Deng Z; Xi M; Zhang C; Wu X; Li Q; Wang C; Fang H; Sun G; Zhang Y; Yang G; Liu Z
ACS Nano; 2023 Mar; 17(5):4495-4506. PubMed ID: 36848115
[TBL] [Abstract][Full Text] [Related]
36. Combinations of immunotherapy and radiation in cancer therapy.
Vatner RE; Cooper BT; Vanpouille-Box C; Demaria S; Formenti SC
Front Oncol; 2014; 4():325. PubMed ID: 25506582
[TBL] [Abstract][Full Text] [Related]
37. Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment.
Rückert M; Deloch L; Frey B; Schlücker E; Fietkau R; Gaipl US
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572437
[TBL] [Abstract][Full Text] [Related]
38. Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.
Baues C; Trommer-Nestler M; Jablonska K; Bröckelmann PJ; Schlaak M; von Bergwelt-Baildon M; Engert A; Semrau R; Marnitz S; Theurich S
Immunotherapy; 2017 Mar; 9(5):423-433. PubMed ID: 28357914
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy: Brightness and darkness in the era of immunotherapy.
Zhai D; An D; Wan C; Yang K
Transl Oncol; 2022 May; 19():101366. PubMed ID: 35219093
[TBL] [Abstract][Full Text] [Related]
40. Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
Thomas S; Kuncheria L; Roulstone V; Kyula JN; Mansfield D; Bommareddy PK; Smith H; Kaufman HL; Harrington KJ; Coffin RS
J Immunother Cancer; 2019 Aug; 7(1):214. PubMed ID: 31399043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
